Less HRT, Fewer Cases of Possible Breast Cancer... (hree to five times increased risk of dev...)

Less HRT, Fewer Cases of Possible Breast Cancer Precursor

Date:11/12/2009

hree to five times increased risk of developing breast cancer, either in the same breast or the opposite breast.

Atypical ductal hyperplasia "is a benign condition but it is a risk factor for breast cancer. It's not clear if it's a precursor to breast cancer," said Miglioretti, who is a senior investigator with the Group Health Research Institute in Seattle. "This sheds light on more of the breast process, how HRT affects breast cancer."

Miglioretti and her co-authors analyzed almost 2.5 million screening mammographies from samples provided by the Breast Cancer Surveillance Consortium. The mammograms were done between 1996 and 2005.

In 1999, atypical ductal hyperplasia was found in 5.5 per 10,000 mammograms but by 2005 had declined to only 2.4 per 10,000, a drop of more than half. This occurred despite an increase over time of rates of mammography, which tend to pick up the abnormality.

Meanwhile, breast cancer cases in women with atypical ductal hyperplasia declined from 4.3 per 10,000 mammograms in 2003 to 3.3 per 10,000 mammograms in 2005.

And postmenopausal use of hormone therapy dropped from 35 percent to 11 percent.

The study also revealed that cancers associated with atypical ductal hyperplasia tend to be less aggressive, lending support to the theory that less aggressive and more aggressive cancers develop differently, the authors stated.

One breast cancer expert said the new study dovetails with recent trends in breast cancer incidence.

"The finding they report is consistent with [previous] observations that suggested there was a drop in incidence of breast cancer in about 2003 and it coincided with when the Women's Health Initiative reported that estrogen-plus-progesterone use was associated with an increased risk of heart attacks as well as a slight increased incidence of breast cancer risk," said Dr. James Liu, chairman of obstetrics and gynecology at MacDonald Women's
'/>"/>

1

GOOD

Page: 1 2 3
Related medicine news :

1. Black gay men, lesbians, have fewer mental disorders than whites, says Mailman School of PH study
2. Fewer adverse cardiac events at one year
3. Hispanics Receive Fewer Surgeries for Vascular Disease
4. Fewer Women Getting Mammograms
5. Fewer Children Outgrowing Allergies to Milk, Eggs
6. Rural Residents Get Fewer Organ Transplants: Study
7. Children who have an active father figure have fewer psychological and behavioral problems
8. Single reader with CAD more efficient, yields fewer false positives, and possibly more sensitive
9. Fewer Steps Per Day Send Disease Markers Up
10. Breast Cancer Radiation Therapy Works in Fewer, But Higher Doses
11. Overweight kids have fewer cavities, new study shows

Post Your Comments:

(Date:3/18/2010)... Taxes, Other Tobacco Prevention Initiatives , ... , , ... ... ... WASHINGTON , March 18 Kids in New Jersey will take center stage in the fight against tobacco on March ...

(Date:3/18/2010)... ... , , ... ... ... New Hampshire will take center stage in the fight against tobacco on March 24 as they join thousands of young people nationwide ...

(Date:3/18/2010)... President and CEO, Legacy(SM) , ... , , ... ... WASHINGTON , March ... ...

(Date:3/18/2010)... of U.S. medical students choosing internal medicine residencies ... significantly impact the shortage of primary care physicians. ... Program report, 2,722 U.S. seniors at medical schools ... 3.4 percent increase from 2,632 in 2009. The ... (2,660), 2007 (2,680), and 2006 (2,668). In comparison, ...

(Date:3/18/2010)... In its 21-year history, under the ... leaders, SRLA has trained more than 40,000 teenagers from ... area to complete the 26.2 mile Los Angeles Marathon. ... volunteer leaders will again participate in the LA Marathon. ... SRLA,s mission is to challenge at-risk secondary students to ...

Breaking Medicine News(10 mins):Health News:New Jersey Kids 'Kick Butts' on March 24 2 Health News:New Jersey Kids 'Kick Butts' on March 24 3 Health News:New Jersey Kids 'Kick Butts' on March 24 4 Health News:New Jersey Kids 'Kick Butts' on March 24 5 Health News:New Hampshire Kids 'Kick Butts' on March 24 2 Health News:New Hampshire Kids 'Kick Butts' on March 24 3 Health News:New Hampshire Kids 'Kick Butts' on March 24 4 Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 2 Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 3 Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 4 Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 5 Health News:Residency match results not encouraging for adults needing primary care 2 Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 2 Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 3

[0] New Jersey Kids 'Kick Butts' on March 24 [0] New Hampshire Kids 'Kick Butts' on March 24 [0] Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco [0] Residency match results not encouraging for adults needing primary care [0] Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years

... French . , Montreal, April 14 2009 ... rule seems to apply to most diseases except HIV-AIDS, which ... called "CD4+" cells have disappeared. The results of a North ... of the Research Institute of the MUHC, run contrary to ...

... offer added flavors, antioxidants and nutritional benefits; Packaging now ... new wave of excitement to the enhanced water category, ... a low-calorie, nutrient enhanced water beverage designed to help ... 10 calories per serving(1), Propel is available ...

... Warns of Effects From Bleeding to Drug Interactions NEW ... or "herbal" are virtually synonymous with safety and purity. ... mistakenly believed to be free of significant risks. A ... warns that more than 40% of plastic surgery patients ...

... SAN FRANCISCO, April 14 Deloitte today released a ... of follow-on biologics, that explores the debate on ... biologics (FOBs), drugs that are envisioned as the biotech ... that have recently been introduced in Congress, both based ...

... guide to showcase Malaysia,s world-class medical facilities , ... ... of Private Hospitals of Malaysia (APHM) jointly announce the launch of ... for international distribution. The Malaysia Edition will be formally launched on ...

... sole marketing exclusivityPITTSBURGH, April 14 Mylan Inc. (Nasdaq: ... and its subsidiary Mylan Pharmaceuticals Inc. have been sued ... of an Abbreviated New Drug Application (ANDA) with the ... 150 mg and 500 mg, the generic version of ...

Other Medicine News:Health News:Treating HIV earlier to decrease the risk of death 2 Health News:Propel Unveils New Enhanced Experience 2 Health News:Propel Unveils New Enhanced Experience 3 Health News:Are Herbal Supplements Putting Aesthetic Surgery Patients at Risk? 2 Health News:Are Herbal Supplements Putting Aesthetic Surgery Patients at Risk? 3 Health News:Are Herbal Supplements Putting Aesthetic Surgery Patients at Risk? 4 Health News:Avoiding No Man's Land: New Deloitte Study on Follow-on Biologics Investigates Proposed Legislation and Possible Unintended Consequences 2 Health News:Avoiding No Man's Land: New Deloitte Study on Follow-on Biologics Investigates Proposed Legislation and Possible Unintended Consequences 3 Health News:Avoiding No Man's Land: New Deloitte Study on Follow-on Biologics Investigates Proposed Legislation and Possible Unintended Consequences 4 Health News:Patients Beyond Borders Malaysia Edition to Launch in July 2 Health News:Patients Beyond Borders Malaysia Edition to Launch in July 3 Health News:Mylan Confirms First-to-File Patent Challenge Relating to Xeloda(R) Cancer Treatment 2

Treating HIV earlier to decrease the risk of death Propel Unveils New Enhanced Experience Are Herbal Supplements Putting Aesthetic Surgery Patients at Risk?Avoiding No Man's Land: New Deloitte Study on Follow-on Biologics Investigates Proposed Legislation and Possible Unintended Consequences Patients Beyond Borders Malaysia Edition to Launch in July Mylan Confirms First-to-File Patent Challenge Relating to Xeloda(R) Cancer Treatment

(Date:3/18/2010)... March 18 Poniard Pharmaceuticals, Inc. ... innovative oncology therapies, today announced that the U.S. Patent ... the composition of matter patent for picoplatin as RE41209, ... 2010 . The reissue was applied for May ... , the USPTO released the "Issue Notification" for the ...

(Date:3/18/2010)... , March 18 ... Chief Executive Officer, Pfizer, was elected board ... of America (PhRMA) today at the trade ... Chief Executive Officer Christopher Viehbacher ... Directors, and John C. Lechleiter , ...

(Date:3/18/2010)... results in too much ammonia in the blood. , ... , , ... ... (Logo: ... ...

Breaking Medicine Technology:U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 2 U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 3 U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 4 U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 5 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 2 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 3 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 4 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 5 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 6 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 7 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 8 FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 2 FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 3 FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 4 FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 5 Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 1 Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 2 Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 3 Exposure to lead tobacco smoke raises risk of ADHD 10856 1 Exposure to lead tobacco smoke raises risk of ADHD 10856 2 Measuring and modeling blood flow in malaria 61892 1 Measuring and modeling blood flow in malaria 61892 2

[0] U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter [0] Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts [0] FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels

... Pharmacopeia Elects to Expand Study to Include 1,000 mg ... PCOP ), an innovator in the discovery and development ... initial results,from the Company,s Phase 1 multiple ascending dose ... no safety or tolerability,issues were observed with any of ...

... Sept. 12 Alfacell Corporation,(Nasdaq: ACEL ) ... events,(patient deaths) have occurred in the Phase IIIb ... treatment of patients with unresectable,malignant mesothelioma. The number ... that total events in the study had reached ...

Other Medicine Technology:Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA) 2 Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA) 3 Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA) 4 Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 2 Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 3

Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program

The Natural Selection family of specialty allografts are spinal allograft devices to eliminate the need for painful autograft harvesting....

... VG2 PLIF Allograft is comprised ... surrounding a cancellous center. The cortical ... support. The cancellous bone provides a ... osteoconductive environment. Superior and inferior surface ...

Williams Micro Discectomy Instruments are designed to be used in the microsurgical treatment of herniated disks....

Meyerding Laminectomy Retractors, self-retaining....

Medicine Products:

The Natural Selection VG2 PLIF Allograft Williams Micro Discectomy Instruments Meyerding Laminectomy Retractors

Less HRT, Fewer Cases of Possible Breast Cancer...(hree to five times increased risk of dev...),Health